More Brain Bleeds With Stroke Drug in 'Real World’
BOSTON -- Intracerebral hemorrhage was more common among patients receiving tissue plasminogen activator (tPA) in the real world compared with those in a clinical trial, a small, single-center study showed.
May 28, 2014